A health products manufacturer is getting into ever deeper financial trouble and the three BDCs involved appear likely to face a debt-for-equity swap, or a realized loss, or both.
This post is for paying subscribers only
You might also like...
Oct
30
Eagle Football Holdings Bidco Ltd: Placed On Non-Accrual
2 min read
Oct
27
Ares Capital: IIQ 2025 Credit Performance, Rating and Outlook